Slide 1: Q2'FY26 Earnings Call Supplemental Presentation
Q2’FY26 Earnings Call Supplemental Presentation February 4, 2026
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looki
Slide 3: Vision and Mission
Vision and Mission To expand the curative power of radiation therapy to improve as many lives as possible. To think, act, and execute beyond expectations every day to deliver better, safer radiation therapy solutions and help patients get back to living their lives, faster. Proprietary and Confident
Slide 4: Q2'FY26 and 1H'FY26 Financials
Q2’FY26 and 1H’FY26 Financials Strong financial performance Q2 FY’26 Highlights KEY FINANCIAL METRICS As a key part of our recurring revenue growth $M Q2 Y/Y 1H Y/Y strategy, service revenue continues to grow due to growth in install base and favorable pricing impacts. Revenues $102.2M -12% $196.2
Slide 5: China Deferred Margin Impact
China Deferred Margin Impact Total Deferral Impact FY25 FY26 Due to JV accounting rules, 49% $k YTD Q1 Q2 of total margin is deferred upon Net China Margin Impact (Deferral) / Release (7,666) (1,081) 1,220 shipment to the JV and margin is released when the JV ships the Total Gross Margin % Reporte
Slide 6: FY26 Guidance
FY26 Guidance $ in millions Revised Guidance Previous Guidance % = YoY Growth Range Range $440M - $450M $471M - $485M Revenue -2% to -4% +3% to +6% [revised] $22M - $25M $31M - $35M Adjusted EBITDA1 -22% to -12% +10% to +25% [revised] 1 Adjusted EBITDA is a non-GAAP measure. Please see Slide 12 for
Slide 7: Thank you
Thank you Proprietary and Confidential Property of Accuray 7
Slide 8: GAAP to Adjusted EBITDA Q2 FY'26 and Q2 FY'25
GAAP to Adjusted EBITDA Q2 FY’26 and Q2 FY’25 Reconciliation of Net Income (Loss) to Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization and Stock-Based Compensation (Adjusted EBITDA) Three Months Ended December 31, $K 2025 2024 GAAP net loss $ (13,770) $ 2,537 Depreciation and amor
Slide 9: GAAP to Adjusted EBITDA 1H FY'26 and 1H FY'25
GAAP to Adjusted EBITDA 1H FY’26 and 1H FY’25 Reconciliation of Net Income (Loss) to Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization and Stock-Based Compensation (Adjusted EBITDA) Six Months Ended December 31, $K 2025 2024 GAAP net loss $ (35,448) $ (1,417) Depreciation and amor
Slide 10: GAAP to Adjusted EBITDA Q1 FY'26 and Q1 FY'25
GAAP to Adjusted EBITDA Q1 FY’26 and Q1 FY’25 Reconciliation of Net Income (Loss) to Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization and Stock-Based Compensation (Adjusted EBITDA) Three Months Ended September 30, $K 2025 2024 GAAP net loss $ (21,678) $ (3,954) Depreciation and a
Slide 11: GAAP to Adjusted EBITDA FY2025
GAAP to Adjusted EBITDA FY2025 Reconciliation of Net Income (Loss) to Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization and Stock-Based Compensation (Adjusted EBITDA) Twelve Months Ended June 30, $K 2025 GAAP net loss $ (1,591) Depreciation and amortization 6,150 Stock-based compe
Slide 12: GAAP to Adjusted EBITDA FY'26 – Forward Looking Guidance
GAAP to Adjusted EBITDA FY’26 – Forward Looking Guidance Reconciliation of Net Income (Loss) to Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization and Stock-Based Compensation (Adjusted EBITDA) Twelve Months Ended June 30, 2026 $K From To GAAP net loss $ (39,000) $ (36,000) Depreci
Slide 13: Gross Margin to Gross Margin Excluding China Margin Impact Q2 FY'26
Gross Margin to Gross Margin Excluding China Margin Impact Q2 FY’26 Reconciliation of Gross margin to Gross margin excluding China Margin Impact Three Months Ended December 31, $K 2025 Total Net Revenue $ 102,241 Total Cost of Revenue (78,169) Gross Profit 24,072 China Margin Release 1,220 Gross Pro
Slide 14: Gross Margin to Gross Margin Excluding China Margin Impact Q1 FY'26
Gross Margin to Gross Margin Excluding China Margin Impact Q1 FY’26 Reconciliation of Gross margin to Gross margin excluding China Margin Impact Three Months Ended September 30, $K 2025 Total Net Revenue $ 93,942 Total Cost of Revenue (66,931) Gross Profit 27,011 China Margin Deferral (1,081) Gross
Slide 15: Gross Margin to Gross Margin Excluding China Margin Impact FY25
Gross Margin to Gross Margin Excluding China Margin Impact FY25 Reconciliation of Gross margin to Gross margin excluding China Margin Impact Twelve Months Ended June 30, $K 2025 Total Net Revenue $ 458,505 Total Cost of Revenue (311,538) Gross Profit 146,967 China Margin Deferral (7,666) Gross Profi